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Abstract
Interventional cancer clinical trials are generally too restrictive, and some
patients are often excluded on the basis of comorbidity, past or concomitant
treatments, or the fact that they are over a certain age. The efficacy and
safety of new treatments for patients with these characteristics are, therefore,
not defined. In this work, we built a model to automatically predict whether
short clinical statements were considered inclusion or exclusion criteria. We
used protocols from cancer clinical trials that were available in public reg-
istries from the last 18 years to train word-embeddings, and we constructed
a dataset of 6M short free-texts labeled as eligible or not eligible. A text
classifier was trained using deep neural networks, with pre-trained word-
embeddings as inputs, to predict whether or not short free-text statements
describing clinical information were considered eligible. We additionally ana-
lyzed the semantic reasoning of the word-embedding representations obtained
and were able to identify equivalent treatments for a type of tumor analo-
gous with the drugs used to treat other tumors. We show that representation
learning using deep neural networks can be successfully leveraged to extract
the medical knowledge from clinical trial protocols for potentially assisting
practitioners when prescribing treatments.
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1. Introduction
Clinical trials (CTs) provide the evidence needed to determine the safety
and effectiveness of new medical treatments. These trials are the bases em-
ployed for clinical practice guidelines [1] and greatly assist clinicians in their
daily practice when making decisions regarding treatment. However, the el-
igibility criteria used in oncology trials are too restrictive [2]. Patients are
often excluded on the basis of comorbidity, past or concomitant treatments,
or the fact they are over a certain age, and those patients that are selected
do not, therefore, mimic clinical practice. This signifies that the results ob-
tained in CTs cannot be extrapolated to patients if their clinical profiles were
excluded from the clinical trial protocols. Given the clinical characteristics
of particular patients, their type of cancer, and the intended treatment, dis-
covering whether or not they are represented in the corpus of CTs that is
available requires the manual review of numerous eligibility criteria, which is
impracticable for clinicians on a daily basis.
The process would, therefore, greatly benefit from an evidence-based clin-
ical decision support system (CDSS). Briefly, a CDSS could scan free-text
clinical statements from medical records and output the eligibility of the pa-
tient in both completed or ongoing clinical trials based on conditions, cancer
molecular subtypes, medical history, and treatments. Such a CDSS would
have the potential advantages of (1) assessing the representation of the pa-
tient’s case in completed studies to more confidently extrapolate study re-
sults to each patient when prescribing a treatment in clinical practice, and
(2) screening a patient’s eligibility for ongoing clinical trials.
In this work, we constructed a dataset using the clinical trial protocols
published in the largest public registry available, and used it to train and val-
idate a model that is able to predict whether short free-text statements (de-
scribing clinical information, like patients medical history, concomitant medi-
cation, type and features of tumor, such as molecular profiles, cancer therapy,
etc.) are considered as Eligible or Not Eligible criteria in these trials. This
model is intended to inform clinicians whether the results obtained in the
CTs—and, therefore, the recommendation in the standard guidelines—can
be confidently applied to a particular patient. The ultimate goal of this work
is to assess whether representation learning using deep neural networks could
be successfully applied to extract the medical knowledge available on clini-
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cal trial protocols, thus paving the way toward more involved and complex
projects.
In the present work, the text was first preprocessed in order to construct
training and validation sets. After extracting bigrams and word-embeddings
(which are commonly used techniques used to generate semantic representa-
tions), we explored different state-of-the-art classification methods (FastText,
Convolutional Neural Networks (CNN), Support Vector Machines (SVM),
and k-Nearest Neighbors (kNN)). Finally, after validating and comparing
the final classifiers, the model was further tested against an independent
testing set.
The main contributions of this work are as follows:
• We propose a method to learn the eligibility for cancer clinical trials
collected in last 18 years.
• Several classifiers (FastText, CNN, SVM, and kNN) are evaluated using
word-embeddings for eligibility classification.
• Using learned deep representations, CNN and kNN (in this case, with
average word-embeddings) obtain a similar accuracy, outperforming the
other methods evaluated.
• Representation learning extracts medical knowledge in cancer clinical
trials, and word-embeddings are suitable to detect tumor type and
treatment analogies.
• In addition, word-embeddings are also able to cluster semantically re-
lated medical concepts.
The remainder of this paper is organized as follows. Section 2 provides a
brief review of the methods related to the proposed work. Section 3 describes
the dataset constructed and the methodology used, including the details em-
ployed to train the embeddings and the text classifiers. The evaluation results
are detailed in Section 4, along with an analysis of the word-embeddings that
were learned. Finally, Section 5 addresses our conclusions and future work.
2. Related Work
Artificial intelligence methods include, among others, rule-based systems,
traditional machine learning algorithms, and representation learning meth-
ods, such as deep learning architectures.
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Rule-based approaches in Natural Language Processing (NLP) seek to en-
code biomedical knowledge in formal languages in such a way that a computer
can automatically reason about text statements in these formal languages us-
ing logical inference rules. MetaMap [3] is a widely known rule-based process-
ing tool in the broader domain of biomedical language. It is a named-entity
recognition system which identifies concepts from the Unified Medical Lan-
guage System Metathesaurus in text (and MetaMap Lite [4]), the clinical
Text Analysis and Knowledge Extraction System (cTAKES [5]), and DNorm
[6]. Many systems have been built upon those tools. For example, in [7], an
NLP System for Extracting Cancer Phenotypes from Clinical Records was
built to describe cancer cases on the basis of a mention-annotation pipeline
based on an ontology and a cTAKES system, and a phenotype summariza-
tion pipeline based on the Apache Unstructured Information Management
Architecture (UIMA [8]).
With regard to the specific domain of clinical trials, prior work has focused
on the problem of formalizing eligibility criteria using rule-based approaches
and obtaining a computational model that could be used for clinical trial
matching and other semantic reasoning tasks. Several languages could be
applied in order to express eligibility criteria, such as Arden syntax, Gello,
and ERGO, among others. Weng et al. [9] presented a rich overview of
existing options. SemanticCT allows the formalization of eligibility criteria
using Prolog rules [10]. Milian et al. [11] applied ontologies and regular
expressions to express eligibility criteria as semantic queries. However, the
problem of structuring eligibility criteria in clinical trials so as to obtain a
generalizable model still remains unsolved.
Devising formal rules and representations with sufficient complexity to
accurately describe biomedical knowledge is problematic. As an example,
the problem with discrete representations in biomedical taxonomies and on-
tologies is that they miss nuances and new words (e.g., it is impossible for
them to keep up to date with the new drugs in cancer research). In addition,
they are subjective, require human labor to create and adapt them, and it
is hard to compute word similarity accurately. In order to solve these is-
sues, machine learning methods can be trained to acquire this knowledge by
extracting patterns from raw data.
In traditional machine learning, the features employed to train algo-
rithms, such as SVMs or kNN, are usually given, while in representation
learning (deep learning methods such as CNN), these features are learned [12].
Nonetheless, many factors regarding variation influence the semantic inter-
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pretation of the biomedical language, thus making it very difficult to extract
high-level abstract features from raw text. Deep learning solves this central
problem by means of representation learning by introducing representations
that are expressed in terms of other simpler representations.
Deep learning models are beginning to achieve greater accuracy and se-
mantic capabilities [13] than the prior state of the art with regard to various
biomedical tasks, such as automatic clinical text annotation and classifica-
tion. For example, a recent work [14] presented an attentional convolutional
network that predicts medical codes from clinical text. It aggregates informa-
tion from throughout the document using a CNN, and then uses an attention
mechanism to select the most relevant segments for each of the thousands of
possible codes. With regard to clinical text classification tasks, [15] proposed
an approach with which to automatically classify a clinical text at a sentence
level using deep CNNs to represent complex features.
To the best of our knowledge, this work is the first reported study to
explore the use of deep learning techniques in order to directly achieve a
semantic interpretation of eligibility criteria in clinical trials. In contrast to
classic NLP approaches, to build the model, we omitted the constraints and
limitations of previous steps, such as tokenization, stemming, syntactic anal-
ysis, named entity recognition (NER), the tagging of concepts to ontologies,
rule definition, or the manual selection of features.
3. Materials and Methods
The system architecture is shown in Figure 1. Clinical trials statements
were first preprocessed as described in Section 3.1. Then, word-embeddings
were trained,as shown in Section 3.2, and classification to obtain the eligibil-
ity prediction is detailed in Section 3.3.
3.1. Dataset Building
A total of 6,186,572 labeled clinical statements were extracted from 49,201
interventional CT protocols on cancer (the URL for downloading this dataset
is freely available at https://clinicaltrials.gov/ct2/results?term=neoplasm&
type=Intr&show_dow). Each CT downloaded is an XML file that follows a
structure of fields defined by an XML schema of clinical trials [16]. The rel-
evant data for this project are derived from the intervention, condition, and
eligibility fields written in unstructured free-text language. The information
in the eligibility criteria—both exclusion and inclusion criteria—are sets of
5
Figure 1: System Architecture: The objective of the final model is to predict whether or
not short clinical statements concerning the type of tumor, including the molecular profile,
the oncologic treatment, the medical history, or concomitant medication, were included in
clinical trials.
6
Figure 2: Extraction of labeled short clinical statements. The two example criteria indi-
cated with the arrows were extracted from their original source, preprocessed, and labeled.
phrases and/or sentences displayed in a free format, such as paragraphs, bul-
leted lists, enumeration lists, etc. None of these fields use common standards,
nor do they enforce the use of standardized terms from medical dictionaries
and ontologies. Moreover, the language had the problems of both polysemy
and synonymy.
The original data were exploited by merging eligibility criteria together
with the study condition and intervention, and subsequently transforming
them into lists of short labeled clinical statements that consisted of two ex-
tracted features (see example in Figure 2), the label (Eligible or Not Eligible),
and the processed text that included the original eligibility criterion merged
with the study interventions and the study conditions. These processes are
detailed in the following section.
3.1.1. Text Preprocessing
We transformed all the eligibility criteria into sequences of plain words
(and bigrams) separated by a whitespace. Each eligibility criterion was aug-
mented with information concerning study intervention and cancer type, as
illustrated in Figure 2. This was done by:
• Splitting text into statements: The implementation took into consid-
eration different kinds of bullets and lists, and not mistakenly splitting
into sentences common abbreviations used in mutations and other med-
ical notations, which include dots, semicolons, or hyphens.
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• Removing punctuation, whitespace characters, all non-alphanumeric
symbols, separators, and single-character words from the extracted
text. All the words were lowercase. We decided not to remove stop
words because many of them, such as “or, “and, “on, were semanti-
cally relevant to the clinical statements.
• Transforming numbers, arithmetic signs (+/−), and comparators (¿, ¡,
=, ...) into text.
In order to filter out nonrelevant or useless samples, we discarded all the
studies where the conditions did not include any of the tokens or suffixes in
“cancer, “neoplasm, “oma, or “tumor. Given that the presence or absence of
redundancy in eligibility criteria, both intra- or interstudy, is relevant infor-
mation to be learned by the model, we did not filter out samples by this crite-
ria, so that the original redundancy distribution was preserved in the dataset.
Because preprocessing the entire dataset is a costly process, for those readers
interested in reproducing this work but would like to skip the preprocessing
steps, we made publicly available a random preprocessed subsample (https:
//www.kaggle.com/auriml/eligibilityforcancerclinicaltrials, at sec-
tion Data, Download all) of 106 samples (for details, see Section 3.1.1).
3.1.2. Bigrams
In the scope of this work, we define bigrams as commonly found phrases
that are very frequent in medicine. Some frequent bigrams were detected and
replaced in the text. Bigrams can represent idiomatic phrases (frequently co-
occurring tokens) that are not compositions of the individual words. Feeding
them as a single entity to the word-embedding rather than each of its word
separately, therefore, allows these phrase representations to be learnt. In our
corpus, excluding common terms, such as stop words, was unnecessary when
generating bigrams. Some examples of bigrams in this dataset are: sunitinib
malate, glioblastoma multiforme, immuno histochemistry, von willebrand,
dihydropyrimidine dehydrogenase, li fraumeni, etc.
Phrase (collocation) detection was carried out using the GenSim API [17].
The threshold parameter defines which phrases will be detected on the basis
of their score. The score formula applied [18] is:
score(wi, wj) =
count(wi, wj)− δ
count(wi) · count(wj) (1)
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For this dataset, after several tests, the most suitable threshold was set
to 500, and the discounting coefficient δ was based on a min count of 20. The
discounting factor prevents the occurrence of too many phrases consisting of
very infrequent words. A total of 875 different bigrams were retrieved from
the corpus and substituted in the text.
3.1.3. Data Augmentation
In this work, data augmentation consisted of adding the cancer types
and interventions being studied to each criterion using statements such as:
“patients diagnosed with [cancer type]”.
In the case of CTs that studied multiple cancer types or interventions,
we replicated each criterion for each intervention and condition, increasing
the number of prototypes.
3.1.4. Labeling
After preprocessing and cleaning the data, the available set had 6,186,572
short clinical statements containing a total of 148,038,397 words. The vo-
cabulary consisted of 49,222 different words. Each statement had in average
23.9 words with a range from 6 to 439 words. The distribution of number of
words by statement had a mean = 23.9, variance = 171.3, skewness = 3.13,
and kurtosis = 21.05.
For the ground truth, we automatically labeled the clinical statements -
previously processed from the eligibility criteria, study conditions, and in-
terventions - as “Eligible (inclusion criterion) or “Not Eligible (exclusion
criterion) on the basis of:
• Their position in relation to the sentences “inclusion criteria” or “ex-
clusion criteria”, which usually preceded the respective lists. If those
phrases were not found, then the statement was labeled “Eligible”.
• Negation identification and transformation: negated inclusion criteria
starting with “no were transformed into positive statements and labeled
“Not Eligible”. All other possible means of negating statements were
expected to be handled intrinsically by the classifier.
The classes were unbalanced, and only 39% of them were labeled as Not
Eligible, while 61% were labeled as Eligible. As the dataset was sufficiently
large, we used random balanced undersampling [19] to correct it, resulting
in a reduced dataset with 4,071,474 labeled samples. The eligibility variable
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containing the text for each criterion, as expected in NLP, has a highly sparse
distribution and only 450 entries were repeated.
3.2. Embedding Training
We used two different approaches (FastText [20] and Gensim [17]) to
generate Word2Vec embeddings based on the skip-gram and CBOW mod-
els [21]. Word2vec [18] is a predictive model that uses raw text as input
and learns a word by predicting its surrounding context (continuous BoW
model) or predicts a word given its surrounding context (skip-gram model)
using gradient descent with randomly initialized vectors. In this work, we
used the Word2Vec skip-gram model. The main differentiating characteristic
of FastText embeddings, which apply char n-grams, is that they take into
account the internal structure or words while learning word representations
[20]. This is especially useful for morphologically rich languages. FastText
models with char n-grams perform significantly better when carrying out syn-
tactic tasks than semantic tasks, because the syntactic questions are related
to the morphology of the words.
We explored different visualizations projecting the trained word-embeddings
into the vector space (Sections 4.5.1 and 4.5.2), grouped terms in semantic
clusters (Section 4.5.3), and qualitatively evaluated the embeddings accord-
ing to their capacity to extract word analogies (Section 4.5.4).
Table 1 shows the best hyperparameters found to generate 100 dimen-
sional embeddings with the FastText and Gensim Word2Vec models. A ran-
dom search strategy [22] was used in order to optimize the values of these
parameters. The Gensim model was trained with three workers on a final
vocabulary of 22,489 words using both skip-grams and CBOW models.
3.3. Classifier Training
Once the word-embeddings were extracted, the next stage consisted of
sentence classification. For this, we explored four methods: Deep Convolu-
tional Neural Networks [13] with or without pre-trained word-embeddings
at the input layer, FastText [23], Support Vector Machines (SVM), and k-
Nearest Neighbors (kNN).
Learning curves were built for all models with increasing dataset sizes (1K,
10K, 100K, 1M, and 4.07 M samples). Each dataset was sampled from the
full dataset, applying random balanced sampling so that, for each resulting
dataset, both label classes (“Eligible” and “Not Eligible”) had the same
number of samples. We split each dataset into 80% samples for the training
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Table 1: Word2Vec hyperparameters using FastText and GenSim. Optimization was
performed using random search [22].
Hyperparameter FastText GenSim
Learning rate 0.025 0.025
Size of word vectors 100 100
Size of the context window 5 5
Number of epochs 5 5
Min. number of word occurrences 5 5
Num. of negative sampled 5 5
Loss function negative sampling negative sampling
Sampling threshold 10−4 10−3
Number of buckets 2,000,000
Minimum length of char n-gram 3
Maximum length of char n-gram 6
Rate of updates for the learning rate 100
set and 20% for the test set. A standard 5-fold cross-validation was then
performed for each dataset size.
Because the accuracy concerning sentence classification depends on the
dataset evaluated and we were unable to find any previous reports that used
the present corpus for text classification, there are no clearly defined bench-
marks with which to perform a comparison.
For example, in different domains, the reported accuracy for classifying
the “Hacker News” posts into 20 different categories using a similar method
was 95%, while in the case of Movie reviews, the reported performance was
81.5% [24]. In the medical domain, a high-performance model is potentially
useful in a CDSS. Using previously published computer-aid systems and re-
lated work [25, 26, 27] as a basis, we defined the minimum target as an
accuracy of 90%, and a Cohen’s Kappa with a minimum of [0.61–0.80] for
substantial agreement, or [0.81–1] for an almost perfect agreement [28].
3.3.1. FastText
FastText [20, 23] for supervised learning is a computationally efficient
method that starts with an embedding layer which maps the vocabulary in-
dexes into d dimensions or, alternatively, it can use pre-trained word vectors.
It then adds a global average pooling layer, which averages the embeddings
of all the words in the sentence. Finally, it projects it onto a single unit
output layer and squashes it with a sigmoid.
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3.3.2. Convolutional Neural Network
In the first experiment, the pre-trained word-embeddings were used as
the input for the 1D CNN model, which has a final dense output layer. In
a different experiment, we also trained the word-embeddings for our classifi-
cation task from scratch. As the training data was sufficiently large and the
vocabulary coverage was also appropriate for the cancer research domain, it
was expected that the model would benefit from training the embeddings in
this particular domain.
We used the Keras [29] library to build a CNN topology (see Table 2),
inspired by the text classifier model for the 20 Newsgroup datasets [30]. After
the necessary adaptations, we followed the steps shown below:
1. Convert all the sentences in the dataset into sequences of word indexes.
A word index is simply an integer identifier for the word. We considered
only the top 20,000 most commonly occurring words in the dataset, and
truncated the sequences to a maximum length of 1000 words.
2. Shuffle, stratify, and split sequences of word indexes into training (80%)
and validation sets (20%).
3. Prepare an embedding matrix which contains at index i the embedding
vector for the word from index i. We loaded this embedding matrix into
an embedding layer which was frozen (i.e., its weights, the embedding
vectors, were not updated during training).
4. A 1D CNN ending in a Softmax layer with two classes was built on top
of it.
5. During training, the data were shuffled with random seed before each
epoch (we used 10 epochs).
3.3.3. SVM
A support vector machine [31] constructs a hyperplane or set of hyper-
planes in a high- or infinite-dimensional space, which can be used for classifi-
cation. Intuitively, a good separation is achieved by the hyperplane that has
the largest distance to the nearest training data points of any class (so-called
functional margin), since, in general, the larger the margin, the lower the
generalization error of the classifier. We trained an SVM model with the
following hyper-parameters selected using exhaustive grid-search optimiza-
tion: penalty parameter C or the error term = 1, kernel = rbf, kernel gamma
coefficient = 1, shrinking heuristic = True, tolerance for stopping criterion
= 0.001.
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Table 2: CNN topology used in this work. The architecture was chosen after evaluating the
accuracy on the test set using different kernel sizes, number of layers, activation functions,
etc.
Layer Description
Input 1000 × 100 dimensional embedded word sequences
Convolution 128 5 × 1 convolutions with stride 1 and ReLu activation
Max Pooling 5 × 1 max pooling with stride 1
Convolution 128 5 × 1 convolutions with stride 1 and ReLu activation
Max Pooling 5 × 1 max pooling with stride 1
Convolution 128 5 × 1 convolutions with stride 1 and ReLu activation
Max Pooling 35 × 1 max pooling with stride 1
Fully Connected 128 fully connected layer with ReLu activation
Fully Connected 2 fully connected layer with Softmax activation
For each short clinical statement, its pre-trained word-embeddings (ob-
tained with FastText using the skip-gram model, as explained in Section
3.2) were used to calculate an average vector of dimension 100 for each clin-
ical statement. Therefore, given a statement, an average vector of word-
embeddings serves as input to the SVM. This representation was chosen to
reduce the dimensionality of the input data.
3.3.4. kNN
Neighbors-based classification is a type of instance-based learning or non-
generalizing learning: it does not attempt to construct a general internal
model, but simply stores instances of the training data. Classification is
computed from a simple majority vote of the nearest neighbors of each point:
a query point is assigned the data class which has the most representatives
within the nearest neighbors of the point. The same input data used for
SVM were evaluated using kNN. We trained a kNN model with the following
hyper-parameters selected using exhaustive grid-search optimization: num-
ber of neighbors = 3, uniform weight for all points in each neighborhood,
and Euclidean distance metric.
4. Results
4.1. Metrics
The performance of the models was calculated using the F-measure (F1),
precision and recall, the confusion matrix, and the coefficient of agreement.
Precision (also called positive predictive value) is the fraction of retrieved
instances that are relevant. Recall (also known as sensitivity) is the fraction
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of relevant instances that are retrieved. Precision, Recall, and F1, which is
the harmonic mean of precision and sensitivity, are calculated as:
Precision =
TP
TP + FP
Recall =
TP
TP + FN
F1 = 2× Precision · Recall
Precision + Recall
where TP (true positives) denotes the number of correct predictions, FP
(false positives) is the number of “Not Eligible labels wrongly predicted as
“Eligible, and FN (false negatives) is the number of “Eligible labels wrongly
declared as “Not Eligible.
Cohen’s Kappa (κ) is a statistic that measures the inter-rater agreement
for qualitative (categorical) items. It is generally considered to be a more
robust measure than a simple percent agreement calculation, since κ takes
into account the possibility of the agreement occurring by chance [32]. It is
calculated as:
κ =
po − pe
1− pe = 1−
1− po
1− pe (2)
where po is the relative observed agreement among raters, and pe is the
hypothetical probability of a chance agreement, using the observed data to
calculate the probabilities of each observer randomly yielding each category.
4.2. Model Evaluation and Validation
All the models were evaluated using different configurations of hyper-
parameters, and the best results obtained for each classifier are given in
Table 3. This section details the classifier settings to get these results, and
analyzes the learning curves that can be seen in Figure 3.
4.2.1. FastText Classifier Results
In order to choose the parameters for the FastText model, we compared
the F1 between successive experiments. Using a random search [22] strategy
for hyperparameter search, the best results were obtained with 100 dimen-
sions and a learning rate of 0.1, as shown in Table 4.
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Table 3: Overall results on the validation set for all the classifiers using a dataset of 106
samples and the full dataset (4.1 × 106) samples. Both experiments were performed using
20% of the prototypes for validation and 80% for training. The best results are marked in
bold.
Classifier Dataset Size Precision Recall F1 Cohen’s κ
FastText
106 0.88 0.86 0.87 0.75
4.1 × 106 0.89 0.87 0.88 0.76
CNN
106 0.88 0.88 0.88 0.76
4.1 × 106 0.91 0.91 0.91 0.83
SVM
106 0.79 0.79 0.79 0.57
4.1 × 106 0.79 0.79 0.79 0.58
kNN
106 0.92 0.92 0.92 0.83
4.1 × 106 0.93 0.93 0.93 0.84
(a) FastText (b) CNN
(c) SVM (d) kNN
Figure 3: Learning curves with 5-fold cross-validation on the FastText, Convolutional
Neural Network (CNN), Support Vector Machine (SVM), and k-Nearest Neighbors (kNN)
classifiers. Horizontal axes show the total training samples, whereas vertical axes are the
F1-score. The green region represents the standard deviation of the models.
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Table 4: FastText classifier hyper-parameters. Optimization was performed using random
search [22].
Hyper-parameter Value
Learning rate 0.1
Size of word vectors 100
Size of the context window 5
Number of epochs 100
Minimum number of word occurences 1
Number of negatives sampled 5
Loss function Softmax
Minimum length of char n-gram 0
Maximum length of char n-gram 0
Maximum length of word n-gram 1
Sampling threshold 10−4
Rate of updates for the learning rate 100
Use of pre-trained word vectors for supervised learning Yes
We also tested the predictive performance of this model when using or
not using pregenerated bigrams, but there was no significant impact on the
results, as shown in Figure 4.
The F1 achieved when using 10
6 samples (800K for training) was 0.87 (see
Table 3). The Cohen’s Kappa coefficient of agreement between the predicted
and the true labels in the validation set was κ = 0.75, which is regarded as a
substantial agreement. The results did not improve significantly when using
the full dataset of 4.1 × 106 samples. In this case, the F1 achieved was 0.88
with a Cohen’s Kappa coefficient κ = 0.76.
The learning curve (Figure 4) shows the evolution of the F1 during train-
ing when the number of training samples was increased from 800 to 800K.
The curve converged with the score obtained in the training sample to a
maximum of 0.88 when using the full dataset, as shown in Table 3. The
validation score converges with the training score, and the estimator does
not benefit much from more training data, denoting a bias error. It has been
reported that the phenomenon of not being able to increase the performance
with additional data can be overcome with the use of deep learning models
applied to complex problems, in contrast to a fast but thin architecture such
as FastText (as will be proved later when using CNNs). On the contrary,
the model did not suffer from a variance error. Cross-validation was used
to assess how well the results of the model generalized to unseen datasets
and obtained robust average validation results with a decreasing standard
16
(a) With bigrams (b) Without bigrams
Figure 4: Learning curves with 5-fold cross-validation on the FastText classifier using as
input pre-trained word-embeddings learned (a) with bigrams and (b) without bigrams.
The green region represents the standard deviation of the model.
Table 5: CNN classifier hyper-parameters.
Hyper-parameter Value
Batch size 128
Learning rate 0.001
Size of word vectors 100
Number of epochs 10
Max number of words 20,000
Max sequence length 1000
Loss function Categorical cross-entropy
Optimizer RMSProp
RMSProp rho 0.9
epsilon 10−8
decay 0
deviation over the k folds (Figure 3a).
4.2.2. CNN Classifier Results
The hyper-parameters used to train the CNN model are shown in Table
5. The results obtained when using both Gensim and FastText generated
embeddings were studied, and the F1 obtained was similar when using or
not using pre-trained word-embeddings. Only the number of dimensions and
epochs had a great impact on the performance and the computational cost
of the model.
With regard to the batch size, sizes of 1, 10, 64, 128, and 512 were inves-
tigated and, as expected, the higher the value, the greater the computational
efficiency. The noisiness of the gradient estimate was reduced in batch sizes
by using higher values. This can be explained by the fact that updating by
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one single sample is noisy when the sample is not a good representation of all
the data. We should consider a batch with a size that is representative of the
whole dataset. For values higher than 128, the predictive performance de-
teriorated in earlier epochs during training and, therefore, we chose a value
of 128. In fact, it has been reported that the loss function landscape of
deep neural networks is such that large-batch methods are almost invariably
attracted to regions with sharp minima [33] and that, unlike small-batch
methods, they are unable to escape the basins of these minimizers. When
using a larger batch, there is consequently a significant degradation in the
quality of the model, as measured by its ability to generalize.
The CNN learning curve (Figure 3b) shows that the network is capable
of generalizing well and that the model is robust. Unlike that which occurs
with the FastText classifier, no overfitting is produced when the dataset is
small.
Nonetheless, it also had a bias error, but, in this case, the model achieved
higher scores for both the training and the validation sets, converging to a
maximum F1 = 0.91, beyond which adding more data does not appear to be
beneficial.
One additional difference with the FastText learning curve is that the
CNN model needs more data to learn, in comparison with FastText. This is
reflected by the fact that the CNN model was underfitting and not properly
learning for a sample size 103 with a validation score of only 0.72, while for
FastText and a sample size 103, the model was clearly overfitting with a
training score close to 1.
The model of the whole dataset, using 3,257,179 training examples, bi-
grams, and pre-trained word-embeddings, eventually yielded an accuracy of
0.91 for the validation set comprising 814,295 samples. The coefficient of
agreement between the predicted and the true labels in the validation set
was κ = 0.83 (see Table 3), which is regarded as an almost perfect agreement
and implies that the model is reliable.
4.3. SVM Classifier Results
The learning curve (Figure 3c) shows the evolution of the F1 during train-
ing when the number of training samples was increased from 800 to 800K.
The curve converged with the score obtained in the training sample to a
maximum of 0.79 when using the full dataset, as shown in Table 3. The
validation score converges with the training score, and the estimator does
not benefit much from more training data, denoting a bias error.
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The F1 achieved when using 10
6 samples (800K for training) was 0.79 (see
Table 3). The Cohen’s Kappa coefficient of agreement between the predicted
and the true labels in the validation set was κ = 0.57. The results did not
improve when using the full dataset of 4.1 × 106 samples. In this case, the
F1 achieved was 0.79 with a Cohen’s Kappa coefficient κ = 0.58.
4.4. kNN Classifier Results
The learning curve (Figure 3d) shows the evolution of the F1 during
training when the number of training samples was increased from 800 to
800K. The validation curve with a maximum of 0.92 still did not reach the
training score obtained in the 800K training sample and further reached 0.93
in the full dataset, as shown in Table 3. This estimator benefited the most,
compared with the other models, from more training data. Nonetheless,
as expected, the computational cost on prediction time was expensive, and
using 106 samples was equivalent to 16 core-hours of CPU.
The F1 achieved when using 10
6 samples (800K for training) was 0.92 (see
Table 3). The Cohen’s Kappa coefficient of agreement between the predicted
and the true labels in the validation set was κ = 0.83, which is regarded as
an almost perfect agreement. The results did not improve significantly when
using the full dataset of 4.1 × 106 samples. In this case, the F1 achieved was
0.93 with a Cohen’s Kappa coefficient κ = 0.84.
4.4.1. Evaluation Using a Clinical Practice Simulation
Finally, in order to assess the potential of the proposed approach as a
clinical decision support system, we checked its performance using a clinical
practice simulation. The two final models were, therefore, further tested
with unseen inputs consisting of a small set (50 samples) of short clinical
statements that would be used in routine clinical practice. Although the
test size is too small to be able to draw meaningful conclusions, the models
yielded very promising results with an accuracy of 0.88 and κ = 0.76. This
favors the hypothesis that it would be possible to generalize such a model to
a different source of data (i.e., routine clinical practice notes) beyond clinical
trial protocol eligibility criteria texts, which was the source used to build and
validate it.
Some examples of correctly classified statements that would require an
expert knowledge of oncology to judge whether or not they are cases being
studied in available clinical trials (Yes/No) are shown below.
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Lapatinib to treat breast cancer with brain metastasis → Yes;
Pertuzumab to treat breast cancer with brain metastasis → No;
CAR to treat lymphoma → Yes;
TCR to treat breast cancer → No.
The performance achieved with the CNN classifier fits expectations with
an F1 = 0.91 and an almost a perfect agreement, outperforming the FastText
results. We can, therefore, conclude that it is possible to address the problem
of predicting whether or not short clinical statements extracted from eligi-
bility criteria are considered eligible in the available corpus of cancer clinical
trials.
4.5. Word-Embeddings
The word-embeddings are an interesting part of this work. Adding pre-
trained embeddings to the classifiers did not alter the classification results.
However, the embeddings were, in themselves, sufficiently interesting to be
qualitatively assessed and discussed using word space visualizations.
4.5.1. t-SNE (t-Distributed Stochastic Neighbor Embedding) Representation
of a Subset of Words
The word-embeddings obtained with FastText, in which each word is
represented in a 100-dimensional space, can be used as a basis on which to
visualize a subset of these words in a reduced space. We use t-Distributed
Stochastic Neighbor Embedding (t-SNE [34]) for this purpose, which is a
dimensionality reduction method that is particularly well suited to the vi-
sualization of high-dimensional datasets. The objective of this algorithm is
to compute the probability distribution of pairs of high-dimensional samples
in such a way that similar prototypes will have a high probability of being
clustered together. The algorithm subsequently projects these probabilities
into the low-dimensional space and optimizes the distance with respect to
the sample’s location in that space.
We defined those words from the complete corpus that we wished to an-
alyze (as it is not possible to visualize all 26,893 words), and obtained the
vectors of these words. The t-SNE representation in Figure 5 shows two as-
pects: on the one hand, the words are grouped by semantic similarities, and
on the other, the clusters seem to follow a spatial distribution in different
regions in a diagonal direction from intrinsic/internal to extrinsic/external
concepts with respect to the human body: [G5] body organs → [G4] body
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Figure 5: Word-embeddings projected into a reduced space with t-Distributed Stochastic
Neighbor Embedding (t-SNE).
symptoms → [G3] infections, cancer and other diseases → [G1,G2] treat-
ments.
4.5.2. Interactive Visualization of the Whole Set of Words
TensorBoard from TensorFlow [35] provides a built-in visualizer, called
the Embedding Projector, for the interactive visualization and analysis of
high-dimensional data. The Word2Vec embeddings obtained with Gensim
were converted into Tensorflow 2D tensor and metadata formats for embed-
ding visualization.
Figure 6 shows an example of these results when using the word “ultra-
sound” as a query. We can appreciate that the 87 nearest points to ultrasound
were all related to explorations, and mainly medical imaging. The nearest
neighbor distances are also consistent when using other concepts. For exam-
ple, Table 6 shows that the model successfully extracted hormonal therapies
from breast cancer as the t-SNE nearest neighbors to “Tamoxifen”.
4.5.3. Word Clusters
We also used the resulting word vectors to generate word clusters fitting
a k-means model [36]. The number of clusters were estimated by applying a
reduction factor of 0.1 to the total number of words to be read (maximum
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Figure 6: Search for “Ultrasound” on the Tensorboard Embedding Projector.
Table 6: Nearest neighbors of “Tamoxifen” using Euclidean distance on the embedding
t-SNE space. All of them are hormonal therapies.
Word Distance
Raloxifene 0.569
Letrozole 0.635
Anastrozole 0.656
Fulvestrant 0.682
Arimidex 0.697
Antiandrogens 0.699
Exemestane 0.715
Aromatase 0.751
Antiestrogens 0.752
Toremifene 0.758
Serm 0.760
Estrogens 0.769
Agonists 0.773
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Table 7: Samples of clustered words.
mri, scan, imaging,
radiographic, mag-
netic, resonance,
scans, abdomen,
radiological, mr,
radiologic, image,
technique, images,
perfusion, sec-
tional, weighted,
spectroscopy, mris,
dce, imaged, lp,
neuroimaging,
volumetric, mrs,
multiparametric,
mrsi, imagery
pelvis, skull, bones,
skeleton, femur,
ribs, sacrum, ster-
num, sacral, lfour,
rib, humerus
pulmonary, respi-
ratory, obstructive,
asthma, copd,
restrictive, emphy-
sema, bronchiec-
tasis, bronchodila-
tor, bronchitis,
bronchospasm,
pneumothorax, ssc,
bronchopulmonary,
cor, expired, onel,
congestion, airflow
abuse, alcohol,
substance, depen-
dence, alcoholism,
addiction, de-
pendency, illicit,
recreational, user,
illegal, misuse,
abusers
10,000). The implementation and resulting clusters can be found at https:
//github.com/auriml/capstone. Upon sampling 20 clusters at random,
a total of 16 were judged to be relevant as to whether their words were
syntactically or semantically related. Some examples are shown in Table 7.
Note that medical abbreviations, such as lfour (L4), mri (Magnetic Res-
onance Imaging), or copd (Chronic Obstructive Pulmonary Disease) were
correctly clustered.
4.5.4. Word Analogies
The word vectors generated were also useful for accurately resolving anal-
ogy problems, such as “Tamoxifen is used to treat breast cancer as X is used
to treat prostate cancer?”. To find the top-N most similar words, we used
the multiplicative combination 3CosMul objective proposed by Levy [37]:
[‘tamoxifen’ − ‘breast + ‘prostate’] ≈ [(‘enzalutamide’, 0.998), (‘antiandro-
gens’, 0.972), (‘abiraterone’, 0.952), (‘finasteride’, 0.950), (‘zoladex’, 0.946),
(‘adt’, 0.933), (‘dutasteride’, 0.927), (‘acetate’, 0.923), (‘flutamide’, 0.916),
(‘leuprolide’, 0.910)]
These are, in fact, very precise results, because all these terms belong
to the hormone-therapy family of drugs which are specifically used to treat
prostatic cancer, and are the equivalents of tamoxifen (hormone-therapy)
for breast cancer. In other words, the model learned the abstract concept
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“hormone-therapy” as a family of drugs and was able to apply it distinctively
depending on the tumor type.
5. Conclusions
In this work, we have trained, validated, and compared various classifiers
(FastText and a CNN with pre-trained word-embeddings, kNN, and SVM)
on a corpus of cancer clinical trial protocols (www.clinicaltrials.gov).
The models classify short free-text sentences describing clinical information
(medical history, concomitant medication, type and features of tumor, such
as molecular profile, cancer therapy, etc.) as eligible or not eligible criteria
for volunteering in these trials. SVM yielded the lowest accuracy results,
and kNN obtained top accuracy performance similar to the CNN model, but
it had the lowest computational performance. Particularly, the high accu-
racy achieved with kNN is the immediate consequence of using as input a
highly efficient clinical statement representation which is based on averaged
pre-trained word-embeddings. A possible reason for this is that the kNN
accuracy relies almost exclusively on using a highly efficient vector represen-
tation as the input data and on the dataset size. Being a non-parametric
method, it is often successful—as in this case—in classification situations
where the decision boundary is very irregular. Nonetheless, in spite of its
high accuracy and the minimal training phase, we favor the use of deep
learning architectures for classification (such as CNN) over a kNN model
because of its lower computational cost during prediction time. In fact, clas-
sifying a given observation requires a rundown of the whole dataset being
too computationally expensive for large dataset as in this work.
All models were evaluated using a 5-fold cross-validation on incremental
sample sizes (1K, 10K, 100K, 1M, samples) and on the largest available
balanced set (using undersampling) with 4.01 million labeled samples from a
total of 6 million. Overall, the models proved robust and had the ability to
generalize. The best performance was achieved with kNN using a balanced
sampling of the whole dataset. The results fit expectations, with an F1 = 0.93
and an agreement of κ = 0.84. The fact that the CNN model outperformed
FastText may be explained by its greater depth, but more efforts should be
made to experiment with alternative CNN topologies.
This CNN model was also evaluated on an independent clinical data
source, thus paving the way toward its potential use—taking into account
pending improvements—in a clinical support system for oncologists when
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employing their clinical notes.
During the experiments, the word-embedding models achieved high-quality
clusters, in addition to demonstrating their capacity for semantic reasoning,
since they were able to identify the equivalent treatments for a type of tumor
by means of an analogy with the drugs used to treat other tumors. These
interesting reasoning qualities merit study in a future work using this dataset.
The evaluation results show that clinical trial protocols related to cancer,
which are freely available, can be meaningfully exploited by applying repre-
sentation learning, including deep learning techniques, thus opening up the
potential to explore more ambitious goals by making the additional efforts
required to build the appropriate dataset.
Our most immediate future work is to use a larger sample test of short
clinical text from medical records for real simulation and include the ef-
fectiveness of CT interventions in the model, thus enabling us to not only
predict whether or not a patients case has been studied, but also whether the
proposed treatment is expected to be effective based on the results of com-
pleted clinical trials for each indication. The problem would be a multilabel
classification task, where the classes would be “effective vs. “non-effective
and “studied vs. “non-studied, and both could be either true or false. This
would allow us to classify from four types of cases: effective and studied, po-
tentially effective but not studied, not effective and studied, and potentially
not effective and not studied. The main effort in this case lies in the dataset
building, which entails including the obtained efficacy results for each study.
As only a subset of CTs (5754 samples, 11%) have the results reported on
clinicaltrials.gov, it means that, for this goal, it would be necessary to
augment data from other sources, such as PubMed [38]. Following prior ef-
fort, a new model could be built to output potential cancer treatments that
could be considered for a particular patient case based on the efficacy results
of completed clinical trials.
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